Getinge to buy Paragonix organ-preserving tech for up to $477M

MedTech Dive August 23, 2024
Ricky Zipp

Getinge will pay $253 million in cash at closing, with additional payments expected to be made between 2024 and 2026 if certain milestones are met.

Dive Brief:

• Getinge has agreed to buy Paragonix Technologies, a maker of devices to preserve organs during transportation, in a deal worth up to $477 million.
• Getinge will pay $253 million in cash at closing, with additional milestone payments that may exceed $224 million, according to the Thursday announcement. The Swedish company expects to make the milestone payments between 2024 and 2026 if certain regulatory and financial goals are met.
• In 2023, Paragonix brought in $43.1 million in revenue, representing year-over-year growth of 136%, a factor Getinge highlighted as motivation for the purchase.

Today's Sponsors

Today's Sponsor